Butixocort aerosol formulations in hydrofluorocarbon propellant
Patent 5653961 Issued on August 5, 1997. Estimated Expiration Date: 
March 31, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
March 31, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesHydrocortisone 17-oxo-21-thioesters and their uses as medicaments Aerosol drug formulations Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content Medicinal aerosol formulations Patent #: 5225183 InventorsApplicationNo. 414370 filed on 03/31/1995US Classes:424/45, Organic pressurized fluid424/46, Powder or dust containing514/958FOR SMOKING OR INHALINGExaminersPrimary: Bawa, RajAttorney, Agent or FirmForeign Patent References
International ClassA61K 009/12AbstractPharmaceutical solution aerosol formulations of butixocort propionate as the sole active drug agent and a propellant selected from the group consisting of 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane, and a mixture thereof.Other References
| |
